Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson's Disease.

International journal of molecular sciences - 8 Sept 2022

López de Frutos Laura, Almeida Francisco, Murillo-Saich Jessica, Conceição Vasco A, Guma Monica, Queheberger Oswald, Giraldo Pilar, Miltenberger-Miltenyi Gabriel

Abstract excerpt

Alterations in the levels of serum sphingolipids and phospholipids have been reported in Gaucher disease and in Parkinson's disease, suggesting a potential role of these lipids as biomarkers. This project's objective is to detect novel associations and novel candidate biomarkers in the largest Spanish Gaucher and Parkinson diseases of the Iberian Peninsula. For that, 278 participants were included: 100 sporadic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Sphingolipids
Share to 1-Deoxynojirimycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Agonists

Share to Gaucher Disease

Share to Phosphatidylcholines

Share to Phosphatidylethanolamines

Share to Phosphatidylglycerols

Share to Phosphatidylserines

Source

Open in PubMed Open full text

Identifiers

PMID: 36142296
DOI: 10.3390/ijms231810387
PMCID: PMC9499334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson's Disease.PMID 36142296Read ↗

Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson’s Disease BrainSemantic proximity Read ↗

Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker DiscoverySemantic proximity Read ↗

Shared and Distinct Lipid Profiles in amygdala from Sporadic and GBA-associated Parkinson’s DiseasesSemantic proximity Read ↗

Plasma sphingolipid abnormalities in neurodegenerative diseasesSemantic proximity Read ↗

Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease.Semantic proximity Read ↗

Metabolomic Changes in Idiopathic and <i>GBA1</i> Parkinson’s DiseaseSemantic proximity Read ↗

Serum lipid alterations in GBA-associated Parkinson's disease.Semantic proximity Read ↗

GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted TherapySemantic proximity Read ↗

CSF Sphingolipids in Parkinson Disease and Dementia with Lewy Bodies with and without GBA1 variantsSemantic proximity Read ↗

Integrative lipidomics of brain and plasma uncovers sex-specific metabolic signatures in Parkinson’s diseaseSemantic proximity Read ↗

Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation.Semantic proximity Read ↗

Advances in mass spectrometry of lipids for the investigation of Niemann-pick type C disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.